DALLAS
ORAL CANCER
SEMINAR
15DF3923
7 31
15
THE
The need for early detection, proper examination and follow through!
4 CE Credits!
$109
COURSE PURPOSE:
Today, oral cancer kills one person in the US every hour; the five-year survival rate has not changed in over
40 years. These are shocking statistics. Its time for these statistics to change. Dentists have tools available that
can enhance early oral cancer detection and its time to recognize what they are. Health care experts now
recommend that all adults beyond the age of 18 receive annual oral cancer screenings. Do dentists know why?
Are dentists seeing everything that they should by merely doing traditional extra/intra-oral screening
examinations? How effective are dentists in dealing with oral cancer detection? Its about time that they know.
THE PROGRAM
INTENDED AUDIENCE
The dentist and the entire
dental team, $109 per attendant
PACKAGE DEAL
4 CE
Credits!
PROGRAM FORMAT
8:00am 8:30am Registration and Breakfast
8:30am 12:30pm Oral Cancer Seminar
Sponsored by
Four key motivating factors to fully engage an oral cancer screening system
How to develop a mission statement for oral cancer screening in the practice
Key statistics for oral cancer: past and present
How to identify the changing target population for oral cancer screening examinations
The steps to the complete visual/white light, extra/intra-oral cancer screening
The why and how of new tools available to enhance screening
How to create seamless referral and follow-up
Communication skills for informed consent to perform oral cancer screenings,
the examination itself, delivering the difficult message of a positive finding,
and creating urgency for effective patient follow-through
SPEAKER
Dennis M. Abbott, D.D.S. is the founder and CEO of Dental Oncology Professionals, an oral medicine
practice dedicated to meeting the unique dental and oral health needs of patients battling cancer. He
holds a Bachelor of Arts in biology from Rice University in Houston, Texas, and is an honor graduate
of Baylor College of Dentistry. After dental school, Dr. Abbott studied immunology, microbiology,
and oral medicine at the School of Dental Medicine, State University of New York at Buffalo.
In addition to private practice, he is a member of the dental oncology medical staff at
Baylor Charles A. Sammons Cancer Center and Baylor University Medical Center in
Dallas. Dr. Abbott also serves as a consultant to the American Cancer Society in the
development of oral monitoring guidelines for post treatment cancer survivors.
He is the previous recipient of the Dentist Scientist Award and the National
Research Service Award, both granted by the National Institutes of Health.
Henry Schein proudly supports the Oral Cancer Cause, (OCC), a 501(c)(3) nonprofit
organization that works to improve the quality of life for oral cancer patients.
For more info on the OCC, please visit: oralcancercause.org